← Back to Search

Peer Navigation for Prostate Cancer

N/A
Waitlist Available
Led By Jackie Bender, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Has been diagnosed with local, locally advanced or stable metastatic PC
Must not have
Is not willing to be randomized
Is receiving palliative care
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Summary

This trial will test whether a new cancer patient navigation program, which pairs patients with trained peer navigators, can improve quality of life, social support and health care service use for men with prostate cancer.

Who is the study for?
This trial is for Canadian men who've recently finished prostate cancer treatment within the last 3 months, can read and speak English, and have an email or are willing to create one. It's not for those with advanced metastatic disease, receiving palliative care, or unwilling to be randomly assigned.Check my eligibility
What is being tested?
The study tests a web-based peer navigation program where men with prostate cancer receive guidance from trained peers online. The goal is to see if this support improves their quality of life and health management compared to usual care plus website information access.See study design
What are the potential side effects?
Since this trial involves a support program rather than medication, traditional side effects like you'd expect from drugs aren't applicable. However, participants may experience emotional impacts from discussing sensitive health issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My prostate cancer is not spreading rapidly.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not open to being randomly assigned to a treatment group.
Select...
I am receiving care focused on relieving symptoms and improving quality of life.
Select...
My cancer has spread to other parts of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Patient Activation at 3 months
Secondary outcome measures
Change in Anxiety
Change in Depression
Change in Fear of Cancer Recurrence
+5 more
Other outcome measures
Intervention cost
Quality-adjusted life year
Total healthcare costs

Trial Design

2Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Participants assigned to the intervention arm will receive the True North Peer Navigation intervention.
Group II: Active Waitlist ControlExperimental Treatment1 Intervention
Participants assigned to the control arm will receive usual care and access to an online health resource library. After completion of the study, they will receive the True North Peer Navigation intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer navigation
2016
Completed Phase 4
~220

Find a Location

Who is running the clinical trial?

University of British ColumbiaOTHER
1,431 Previous Clinical Trials
2,478,719 Total Patients Enrolled
10 Trials studying Prostate Cancer
2,955 Patients Enrolled for Prostate Cancer
Canadian Cancer Society (CCS)OTHER
79 Previous Clinical Trials
37,737 Total Patients Enrolled
7 Trials studying Prostate Cancer
7,441 Patients Enrolled for Prostate Cancer
Walnut FoundationUNKNOWN

Media Library

Peer navigation Clinical Trial Eligibility Overview. Trial Name: NCT05041504 — N/A
Prostate Cancer Research Study Groups: Active Waitlist Control, Intervention
Prostate Cancer Clinical Trial 2023: Peer navigation Highlights & Side Effects. Trial Name: NCT05041504 — N/A
Peer navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05041504 — N/A
~58 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top